Paperback. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Lingua: Inglese
Editore: Elsevier - Health Sciences Division, 2001
ISBN 10: 1560534443 ISBN 13: 9781560534440
Da: Better World Books: West, Reno, NV, U.S.A.
Prima edizione
Condizione: Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Da: WorldofBooks, Goring-By-Sea, WS, Regno Unito
EUR 8,34
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
Da: Goodwill of Silicon Valley, SAN JOSE, CA, U.S.A.
Condizione: acceptable. Supports Goodwill of Silicon Valley job training programs. The cover and pages are in Acceptable condition! Any other included accessories are also in Acceptable condition showing use. Use can include some highlighting and writing, page and cover creases as well as other types visible wear such as cover tears discoloration, staining, marks, scuffs, etc. All pages intact.
Lingua: Inglese
Editore: World Scientific Publishing Comp, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: suffolkbooks, Center moriches, NY, U.S.A.
bundle. Condizione: Very Good. Fast Shipping - Safe and Secure 7 days a week!
Condizione: New. Satisfaction Guaranteed or your money back.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 114,29
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 114,29
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 112,61
Quantità: 10 disponibili
Aggiungi al carrelloPF. Condizione: New.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 129,80
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. pp. XX, 210 27 illus., 26 illus. in color. 1st ed. 2019 edition NO-PA16APR2015-KAP.
Condizione: New.
Da: Revaluation Books, Exeter, Regno Unito
EUR 153,48
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. har/psc edition. 232 pages. 9.25x6.10x0.75 inches. In Stock.
Condizione: New.
Lingua: Inglese
Editore: Springer International Publishing, 2020
ISBN 10: 3030244261 ISBN 13: 9783030244262
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called 'target' therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy.This volume will review different classes of 'target' drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs.Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
Lingua: Inglese
Editore: Springer International Publishing, 2019
ISBN 10: 3030244237 ISBN 13: 9783030244231
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called 'target' therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy.This volume will review different classes of 'target' drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs.Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
EUR 82,55
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called "target" therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy. This volume will review different classes of "target" drugs that have been developed, approved, or are under investigation in the field of lymphoma therapy. The discussion will not only be on the understanding of the mechanisms of action or clinical response of those agents, but will also help the reader to understand the nature of lymphoma biology in patients who relapse or are refractor after exposure to those drugs. Contributors will discuss what is currently known about mechanisms of tumor-related or host-related resistance, and how to overcome this resistance. This understanding is crucial given the dismal outcomes of patients with relapsed or refractory lymphomas. The book provides a unique opportunity to review and reflect on the recent successes and pitfalls of the modern lymphoma therapy era.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 175,94
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. New. book.
Da: Sell Books, Elland, YORKS, Regno Unito
EUR 1.055,62
Quantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: Good. Our good condition books are generally good for reading but not for gifting or collecting. They could have imperfections such as creasing, fanning, inscriptions, margin notes, yellowing, staining on edge or cover or pages, bumps, scuffs, etc etc (sometimes multiple of these). It's a wide category that encompasses anything that isn't almost-new down to anything that is slightly better than poor. We would NOT recommend gifting Good books - these should be considered reading copies. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.
Lingua: Inglese
Editore: World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Lingua: Inglese
Editore: World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Lingua: Inglese
Editore: World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Lingua: Inglese
Editore: World Scientific Publishing Company, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Buchpark, Trebbin, Germania
EUR 29,90
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 600 | Sprache: Englisch | Produktart: Bücher | Bringing together intellectual and scientific experts from pediatrics, adolescent medicine, general medicine, pathology, biology, nursing and psychology, this book is the first of its kind to cover the topics of leukemias and lymphomas in young patients ranging from infants to young adults. The content is organized and subdivided into four major sections under the main headings of General Considerations, Pathobiology, Clinical Manifestations and Treatment, and Supportive Care and Complications for ease of reference to readers. Hematological Malignancies in Children, Adolescents and Young Adults presents a comprehensive multidisciplinary review of the field of hematological malignancies and brings forth illuminating perspectives from an internationally recognized group of leading authorities in the field.
Lingua: Inglese
Editore: World Scientific Publishing Company, Incorporated, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Books Puddle, New York, NY, U.S.A.
Condizione: Used. pp. xix + 580.
Lingua: Inglese
Editore: World Scientific Publishing Company, Incorporated, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Majestic Books, Hounslow, Regno Unito
EUR 153,33
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. xix + 580.
Lingua: Inglese
Editore: World Scientific Publishing Company, Incorporated, 2012
ISBN 10: 981429960X ISBN 13: 9789814299602
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 156,00
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. xix + 580.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 86,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 86,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.